Elipovimab
Product Specifications
CAS Number
2101210-43-7
Target
HIV Protease
Related Pathways
Proteases/Proteasome|||Microbiology/Virology
Bioactivity
Elipovimab, a potent and broadly neutralizing antibody against HIV-1, targets and eliminates HIV-infected cells [1].
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1099857-01 0.02 mg (E-Coli)
Recombinant Campylobacter jejuni subsp. doylei Ketol-acid reductoisomerase (ilvC)
Ask
View Details MBS1099857-02 0.02 mg (Yeast)
Recombinant Campylobacter jejuni subsp. doylei Ketol-acid reductoisomerase (ilvC)
Ask
View Details 
MBS1099857-03 0.1 mg (E-Coli)
Recombinant Campylobacter jejuni subsp. doylei Ketol-acid reductoisomerase (ilvC)
Ask
View Details